Evidence map›Paper›PMID 37669696›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2023

Fine-tuned photochromic sulfonylureas for optical control of beta cell Ca

Ann-Kathrin Rückert, Julia Ast, Annie Hasib, Daniela Nasteska, Katrina Viloria, Johannes Broichhagen, David J Hodson

Open access · hybridAbstract read
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Fine-tuned photochromic sulfonylureas for optical control of beta cell CaDiabetic medicine : a journal of the British Diabetic Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ann-Kathrin RückertLeibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.
Julia AstInstitute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, UK.ORCID 0000-0002-0039-4762
Annie HasibInstitute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, UK.
Daniela NasteskaOxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Katrina ViloriaInstitute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, UK.
Johannes BroichhagenLeibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.ORCID 0000-0003-3084-6595
David J HodsonInstitute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, UK.ORCID 0000-0002-8641-8568
Churchill Hospital · GBLeibniz-Forschungsinstitut für Molekulare Pharmakologie · DENIHR Surgical Reconstruction and Microbiology Research Centre · GB

Funding

Department of HealthMedical Research Council MR/N00275X/1Medical Research Council MR/S025618/1
6 · The paper itself

Abstract

We previously developed, synthesized and tested light-activated sulfonylureas for optical control of K

Indexed as

AzetidinesInsulin-Secreting CellsAdenosine TriphosphateAzo CompoundsHumansPiperidinesPyrrolidinesSulfonylurea CompoundsAdenosine TriphosphateAzetidinesazobenzeneAzo CompoundsPiperidinesPyrrolidinesSulfonylurea Compoundsimaginginsulinisletphotopharmacologysignal transduction

Identifiers

PMID37669696
PMCPMC10947021
OpenAlexW4386448992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.